UNIPHARMA ApS: Financial statements 2024
CVR: 78881917
UNIPHARMA ApS (CVR 78881917) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity amounted to DKK -124,033.
- Gross Profit
- 0 kr.
- Profit/Loss
- 0 kr.
- Equity
- -124,033 kr.
- Total Assets
- 1 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 0 | 0 | -124 t. | - |
| 2023 | - | 0 | 0 | -124 t. | 0 |
| 2022 | 0 | 0 | -88 | 56 t. | - |
| 2021 | - | - | -5 t. | 57 t. | - |
| 2020 | -5 t. | -5 t. | -5 t. | 62 t. | - |
How creditworthy is UNIPHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
UNIPHARMA ApS has published its annual report for 2023. Gross profit came to DKK 0, and the net result was DKK 0.
About UNIPHARMA ApS
UNIPHARMA ApS was a Danish company of the type Anpartsselskab based in København K, founded in 1985. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company is owned by Ebba Dorrit Reumert and Ebba Dorrit Reumert. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity amounted to DKK -124,033.
